Chronic Back Pain Breakthrough Treatment Combats Rising Use Of Opioids For Pain Treatment 



 

Bethlehem, PA — An exciting and innovative treatment recently approved by the FDA provides substantial relief for patients suffering from the severe effects of chronic back and leg pain – without the risk of addiction and abuse. — is now being offered locally at Specialty Spine, Sports & Sports Medicine.
This advanced treatment is being launched across the country and is now being offered by Dr. Scott Naftulin and his team at Specialty Spine, Sports & Pain Medicine, in their Bethlehem and Scranton/Wilkes Barre offices.

Unlike traditional spinal cord stimulation devices, which deliver low-frequency electrical pulses to mask chronic pain with sensations commonly perceived as tingling, prickling, pins-and-needles, or vibrations called paresthesia (which many patients consider to be a nuisance) – the Nevro Sensa’s high-frequency HF10 therapy delivers pain relief without these sensations – a major breakthrough for patients.

“In my 20 years of practice I have not encountered such a dramatically successful treatment for patients suffering from refractory low back pain, either previously operated or not,” said Dr. Naftulin.

Chronic back pain can be debilitating and often interferes with everyday functions. It affects more than 100 million Americans and is the primary cause of disability among adults in the U.S.

Opioid painkillers as a treatment for severe pain has been making headlines in recent years as the increased use has been linked to a rising epidemic of addiction and a possible correlation to opiate-related overdoses.  In July 2016, Congress passed a bipartisan bill to combat opioid addiction in response to the almost 3,000 percent increase in addiction rates over the past decade.

The FDA approval of HF10 therapy came with a label of superiority over traditional spinal cord stimulation therapy – the first and only device of its kind approved with this rating. Two-year safety and effectiveness data from a randomized study of HF10 therapy was recently published in Neurosurgery.
Charles B*, a resident of Bath, PA suffered a work-related injury in 2003. After undergoing back surgery that same year, he was told, “this was the best I would ever be” and put on a regimen of opioid pain medications and injections to help ease his suffering. Within two months of the Nevro device being implanted, Charles has been completely weaned off his pain medication.

When asked about the past two months compared to the past 14 years, he said, “It absolutely changed my life. I have no nerve pain in my back or my legs. It’s incredible!”

For more information on Dr. Naftulin visit specialtyspinecare.com. To learn more about the device visit  HF10therapy.com.

(*Patient’s full name withheld due to federal privacy protection laws. Both Physician and Patient are available for interviews.)

 

Press Release By:
Rick Schoenen
schoenenmarketing@gmail.com